Complex Management of AV Nodal Agent Toxicity in Patients with Cardiac Devices: Massive Calcium Channel Antagonist Overdose in a Patient with a Permanent Pacemaker.

Journal of cardiology case reports Pub Date : 2022-01-01
Patric W Gibbons, Peter R Chai, Timothy B Erickson
{"title":"Complex Management of AV Nodal Agent Toxicity in Patients with Cardiac Devices: Massive Calcium Channel Antagonist Overdose in a Patient with a Permanent Pacemaker.","authors":"Patric W Gibbons,&nbsp;Peter R Chai,&nbsp;Timothy B Erickson","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>We present a unique case of a massive calcium channel antagonist overdose in a patient with a permanent pacemaker. Upon presentation after the acute overdose, the patient's cardiac device was found to be pacing to an adequate rate (75 beats per minute) and she was admitted to the cardiac intensive care unit. Approximately 24 hours after her ingestion, she acutely decompensated and became hypotensive. The patient was started on infusions of norepinephrine, epinephrine, phenylephrine, and vasopressin. Her mean arterial pressure was unresponsive to multi-vasopressor therapy. She was then given a bolus of methylene blue and high-dose insulin euglycemic therapy. Despite these treatments, the patient remained hypotensive Therefore, intralipid emulsion therapy and IV epinephrine pushes were also administered. As a result of her shock and hemodynamic instability, her course was further complicated by hypoxemic respiratory failure for which she required ventilatory support and developed oliguric renal failure for which she was initiated on continuous veno-venous hemofiltration. This case emphasizes the challenges in managing complex physiology associated with nodal agent toxicity and is the first, to our knowledge, to describe management in a patient who already had a pacemaker, though it was ultimately ineffective in avoiding the patient's profound decompensation.</p>","PeriodicalId":73637,"journal":{"name":"Journal of cardiology case reports","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10103801/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cardiology case reports","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

We present a unique case of a massive calcium channel antagonist overdose in a patient with a permanent pacemaker. Upon presentation after the acute overdose, the patient's cardiac device was found to be pacing to an adequate rate (75 beats per minute) and she was admitted to the cardiac intensive care unit. Approximately 24 hours after her ingestion, she acutely decompensated and became hypotensive. The patient was started on infusions of norepinephrine, epinephrine, phenylephrine, and vasopressin. Her mean arterial pressure was unresponsive to multi-vasopressor therapy. She was then given a bolus of methylene blue and high-dose insulin euglycemic therapy. Despite these treatments, the patient remained hypotensive Therefore, intralipid emulsion therapy and IV epinephrine pushes were also administered. As a result of her shock and hemodynamic instability, her course was further complicated by hypoxemic respiratory failure for which she required ventilatory support and developed oliguric renal failure for which she was initiated on continuous veno-venous hemofiltration. This case emphasizes the challenges in managing complex physiology associated with nodal agent toxicity and is the first, to our knowledge, to describe management in a patient who already had a pacemaker, though it was ultimately ineffective in avoiding the patient's profound decompensation.

Abstract Image

Abstract Image

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
心脏装置患者房室结药物毒性的复杂管理:永久性起搏器患者大量钙通道拮抗剂过量。
我们提出了一个独特的情况下,大量钙通道拮抗剂过量的病人与永久起搏器。在急性用药过量后就诊时,发现患者的心脏装置起搏速度正常(每分钟75次),她被送入心脏重症监护病房。摄入后约24小时,患者出现急性代偿失代偿并出现低血压。患者开始输注去甲肾上腺素、肾上腺素、苯肾上腺素和抗利尿激素。她的平均动脉压对多种血管加压药物治疗无反应。随后给予大剂量亚甲蓝和高剂量胰岛素治疗。尽管进行了这些治疗,患者仍然处于低血压状态,因此,脂质乳内治疗和静脉肾上腺素推压也被给予。由于休克和血流动力学不稳定,她的病程因低氧性呼吸衰竭而进一步复杂化,她需要呼吸机支持,并发展为少尿性肾衰竭,她开始持续静脉-静脉血液滤过。据我们所知,该病例强调了管理与结剂毒性相关的复杂生理的挑战,并且是第一个描述已经安装了起搏器的患者的管理,尽管它最终无法避免患者的严重失代偿。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Atrapamiento del tendón tibial posterior en luxofractura irreductible abierta de tobillo: reporte de un caso. Remisión sintomática en una paciente con artritis reumatoidea tratada con Terapia Neural. Reporte de caso Colangitis esclerosante secundaria tras COVID-19 grave. Reporte de caso El sistema inmunológico, un aliado impredecible Tratamiento de una úlcera flebostática en miembro inferior con plasma rico en plaquetas activado con ozono-cloruro de calcio y membranas de fibrina. Reporte de caso
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1